Real-World asthma drug gets Long-Term safety check
NCT ID NCT03588546
First seen Nov 01, 2025 · Last updated Apr 23, 2026 · Updated 22 times
Summary
This study monitored the long-term safety and effectiveness of FASENRA injections in people with severe asthma. It involved 653 patients who were already prescribed this medication for asthma that wasn't controlled by standard treatments. Researchers tracked side effects and how well the drug controlled asthma symptoms over extended use in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Aichi, D3250C00057, Japan
-
Research Site
Akita, D3250C00057, Japan
-
Research Site
Aomori, D3250C00057, Japan
-
Research Site
Chiba, D3250C00057, Japan
-
Research Site
Ehime, D3250C00057, Japan
-
Research Site
Fukuoka, D3250C00057, Japan
-
Research Site
Gunma, D3250C00057, Japan
-
Research Site
Hiroshima, D3250C00057, Japan
-
Research Site
Hokkaido, D3250C00057, Japan
-
Research Site
Hyōgo, D3250C00057, Japan
-
Research Site
Ibaraki, D3250C00057, Japan
-
Research Site
Kagawa, D3250C00057, Japan
-
Research Site
Kagoshima, D3250C00057, Japan
-
Research Site
Kanagawa, D3250C00057, Japan
-
Research Site
Kumamoto, D3250C00057, Japan
-
Research Site
Kyoto, D3250C00057, Japan
-
Research Site
Mie, D3250C00057, Japan
-
Research Site
Miyagi, D3250C00057, Japan
-
Research Site
Numakunai, D3250C00057, Japan
-
Research Site
Okayama, D3250C00057, Japan
-
Research Site
Okinawa, D3250C00057, Japan
-
Research Site
Osaka, D3250C00057, Japan
-
Research Site
Ōita, D3250C00057, Japan
-
Research Site
Saitama, D3250C00057, Japan
-
Research Site
Shiga, D3250C00057, Japan
-
Research Site
Tochigi, D3250C00057, Japan
-
Research Site
Tokyo, D3250C00057, Japan
-
Research Site
Yamagata, D3250C00057, Japan
-
Research Site
Yamaguchi, D3250C00057, Japan
Conditions
Explore the condition pages connected to this study.